Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Vascular-Immune Cells Crosstalk and Microenvironment in Pulmonary Hypertension

  • Navarro-Llinares, Lola
  • García-León, Bertha
  • de la Bastida-Casero, Laura
  • Oliver, Eduardo
Pulmonary hypertension is a disease of the lung vasculature, which eventually leads to heart dysfunction. Despite the advances in the discovery and development of new treatments, most of them are aimed to palliate symptoms. Thus, it is crucial to identify novel potential targets directly acting on vascular remodeling. Further understanding of this pathological event is needed to completely describe the disease's mechanisms and effectively generate therapeutical strategies able to cure the disease. Here, we propose an integrative perspective of studying pulmonary hypertension based on the interactions between the vascular cells and their surroundings. This review describes the crosstalk between vascular cells and immune cells in the diseased vasculature, highlighting the central role of this axis and the importance of healthy cell-to-cell communication. Furthermore, we discuss the possibility of considering the pulmonary microenvironment as a key pathological factor in pulmonary hypertension, This work was supported by funding from Ministerio de Ciencia, Innovación y Universidades/Agencia Estatal de Investigación MCIN/ AEI/10.13039/501100011033 and by “ERDF A way of making Europe” (PID2021- 123167OB- I00, PID2024- 159407OB- I00 and RED2022- 134299- T), CSIC Talent Attraction program (20222AT010) and Ayudas especiales para la preparación de proyectos (2025AEP161), CIBERCV- CIBERNED collaborative funds (CV24PI04/2024), La Marató de TV3 Foundation (202336- 30- 31) and Ayudas para la investigación de la Fundación contra la Hipertensión Pulmonar. L.B.- C. was a recipient of a predoctoral fellowship from Comunidad de Madrid (PIPF- 2022/SAL- GL- 24824). B.G.- L. was a recipient of a Severo Ochoa FPI predoctoral fellowship from Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación (PRE2022- 104403), Peer reviewed, Sin experimentacion animal ni uso de NAMs
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Breakthroughs in our molecular understanding of therapeutic targets for pulmonary hypertension

  • Bredeck, Gerrit
  • Cruz-Utrilla, Alejandro
  • Oliver, Eduardo
Pulmonary hypertension (PH) is characterized by progressive pulmonary vascular remodeling, rising right-ventricular afterload, and eventual maladaptation, which is a major determinant of prognosis. While established therapies mainly target vasoconstrictive pathways, recent development has shifted toward disease-modifying strategies that address remodeling, inflammation, and metabolic dysfunction in PH patients., This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – [555525825], by Ayudas para la investigación de la Fundación contra la Hipertensión Pulmonar, by Ministerio de Ciencia, Innovación y Universidades/Agencia Estatal de Investigación MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” [PID2024-159407OB-I00]. Alejandro Cruz-Utrilla holds a research contract Juan Rodes from the Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades, Spanish Government [JR23/00071]., Peer reviewed